dagger 发表于 2025-3-23 10:21:28
,Importance of Carbohydrate Antigen 19-9 Monitoring in the Management of Pancreatic Cancer,tic cancers demonstrate little to no radiographic changes in response to therapy. Lack of reliable radiographic response remains a major challenge to assessing biologic response to therapy and confounds appropriate surgical selection. In addition, subjectivity and inter-reater variability complicateattenuate 发表于 2025-3-23 14:27:05
http://reply.papertrans.cn/63/6226/622537/622537_12.png北京人起源 发表于 2025-3-23 21:45:34
Treatment Sequencing for Borderline Resectable Pancreatic Cancer,ignificant tumor-vascular interface, patients are at a high risk of margin-positive resection with a surgery first approach. We advocate for a multimodal approach to the management of these patients in order to mitigate this risk. In this chapter we will discuss the rational for use of preoperativeDIS 发表于 2025-3-24 01:14:34
Delivery of Neoadjuvant Versus Adjuvant Therapy in Localized Pancreatic Cancer,States, and almost all are expected to die from the disease . Worldwide, pancreatic cancer is the eighth leading cause of cancer deaths in men (138,100 deaths annually) and the ninth in women (127,900 deaths annually) . It is the third leading cause of cancer-related death in the United States不可思议 发表于 2025-3-24 03:05:24
Neoadjuvant Chemoradiation for Localized Pancreatic Cancer,ion. The role of neoadjuvant or adjuvant therapies in conjunction with surgical resection is well established. The optimal sequencing of these therapies remains controversial. While historically patients with pancreatic cancer were managed with a surgery-first approach, the oncologic rationale for tObscure 发表于 2025-3-24 07:09:53
New Classification of Locally Advanced Pancreatic Cancer, and metastatic disease. These clinical categories provide critical information regarding the resectability status of a tumor based on discreet anatomic criteria gleaned from imaging data. Accurate staging at diagnosis allows clinicians to formulate treatment plans that are consistent and seamless b乐章 发表于 2025-3-24 11:18:56
Treatment Sequencing for Locally Advanced Pancreatic Cancer,n the strengths of each treatment modality. Four to six months minimum of chemotherapy treats micrometastatic disease and selects out patients who are not appropriate candidates for local therapies. Radiation then sterilizes margins and lymph nodes and treats the perineurium known to commonly be inv细查 发表于 2025-3-24 15:18:25
Role of Radiation for Locally Advanced Pancreatic Cancer,uestioned. Given the location of the pancreas in the upper abdomen, the use of radiation in this location is technically challenging. Identification of the patients who will benefit from this treatment is pivotal, as is the expertise to execute radiation to defined targets at the required high dosesMangle 发表于 2025-3-24 22:59:30
http://reply.papertrans.cn/63/6226/622537/622537_19.pngcrumble 发表于 2025-3-25 00:00:17
http://reply.papertrans.cn/63/6226/622537/622537_20.png